Skip to NavigationSkip to content

News

0
Astrazeneca image
Q1 figures continue recent trend but firm remains bullish on prospects for growth
0
sovaldi iamge
High sales of newly-launched hepatitis C treatment surprise analysts
0
Allergan image
Canadian firm puts cards on table for Botox maker following rebuff from board
0
kadcyla image
Watchdog criticises Roche’s pricing but firm and charity hit out at decision

Features

Emmanuel image

The general manager, commercial EMEA of GE Healthcare Life Sciences talks to Pharmafile